In situ cryo-ET visualization of mitochondrial depolarization and mitophagic engulfment

K Kevin Rose (Aligning Science Across Parkinson’s Collaborative Research Network) E Eric Herrmann (Aligning Science Across Parkinson’s Collaborative Research Network) E Eve Kakudji (Aligning Science Across Parkinson’s Collaborative Research Network) J Javier Lizarrondo (Aligning Science Across Parkinson’s Collaborative Research Network) A A. Yasemin Celebi (California Institute for Quantitative Biosciences, University of California Berkeley) F Florian Wilfling (Mechanisms of Cellular Quality Control, Max Planck Institute of Biophysics) S Samantha C. Lewis (Aligning Science Across Parkinson’s Collaborative Research Network) J James H. Hurley

Abstract

Defective mitochondrial quality control in response to loss of mitochondrial membrane polarization is implicated in Parkinson’s disease by mutations in PINK1 and PRKN . Parkin-expressing U2 osteosarcoma (U2OS) cells were treated with the depolarizing agents oligomycin and antimycin A (OA) and subjected to cryo-focused ion beam milling and in situ cryo-electron tomography. Mitochondria were fragmented and devoid of matrix calcium phosphate crystals. Phagophores were visualized, with bridge-like lipid transporter densities connected to mitophagic phagophores. A subpopulation of ATP synthases relocalized from cristae to the inner boundary membrane. The structure of the dome-shaped prohibitin complex, a dodecamer of PHB1-PHB2 dimers, was determined in situ by subtomogram averaging in untreated and treated cells and found to exist in open and closed conformations, with the closed conformation being enriched by OA treatment. These findings provide a set of native snapshots of the manifold nano-structural consequences of mitochondrial depolarization and provide a baseline for future in situ dissection of Parkin-dependent mitophagy.

Article Details

Volume / Issue Vol. 122, Issue 31
Published August 05, 2025
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (8)

K

Kevin Rose

Aligning Science Across Parkinson’s Collaborative Research Network

E

Eric Herrmann

Aligning Science Across Parkinson’s Collaborative Research Network

E

Eve Kakudji

Aligning Science Across Parkinson’s Collaborative Research Network

J

Javier Lizarrondo

Aligning Science Across Parkinson’s Collaborative Research Network

A

A. Yasemin Celebi

California Institute for Quantitative Biosciences, University of California Berkeley

F

Florian Wilfling

Mechanisms of Cellular Quality Control, Max Planck Institute of Biophysics

S

Samantha C. Lewis

Aligning Science Across Parkinson’s Collaborative Research Network

J

James H. Hurley